This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Public markets are just starting to price the potential of quantum computing. This guide explains how to evaluate qua...
A UN FAO economist warns that fertilizer shortages and rising energy costs could push global food prices higher withi...
Boston lands at the top of a key international ranking, signaling rising housing demand tied to corporate relocations...
SpaceX is poised to redefine the IPO window, with investors racing to price in a future where Elon Musk's company goe...
US-listed Bitcoin and Ethereum ETFs faced large redemptions through mid-June, yet niche products like Hyperliquid and...
DeepMind’s 2010 seed and Google’s 2014 buyout sparked debate about exit timing in AI. This report weighs whether the ...
Esther Perel warns that social atrophy is creeping through workplaces, a trend accelerated by AI and hybrid schedules...
A fresh $75 million fund backs consumer brands with cultural punch. The 29-year investor went from early, risky bets ...
A look at why tqqq holders face risk that extends beyond Nasdaq direction, as daily resets and market swings bite lev...
Jack Schlossberg, JFK’s grandson and Manhattan candidate, says Democrats lost touch with young men and explains why h...
As AI agents expand their role in business and everyday life, the race between Intel and AMD intensifies. This guide ...